To further confirm if the inhibition of TGF-β signal without the activation of p53 plays a key role in heteronemin-induced anti-proliferation in cholangiocarcinoma, knockdown studies of TGF-β and p53 were conducted. Here, TGFB1 is linked to cholangiocarcinoma.